leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3
about
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesisOncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsThe integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exerciseThe Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and ProgressionICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATsGlioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effectsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasAdiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.Notch1-Dll4 signalling and mechanical force regulate leader cell formation during collective cell migration.Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.Mediator and human diseaseNILCO biomarkers in breast cancer from Chinese patientsLKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cellsLeptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways.Leptin signaling molecular actions and drug target in hepatocellular carcinomaDual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptorModulation of the leptin receptor mediates tumor growth and migration of pancreatic cancer cells.Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.Med1 plays a critical role in the development of tamoxifen resistance.Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.Zeranol may increase the risk of leptin-induced neoplasia in human breast.G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils.Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumorsHonokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.Multifaceted leptin network: the molecular connection between obesity and breast cancer.Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cellsMolecular pathways: adiponectin and leptin signaling in cancer.Obesity, energy balance, and cancer: new opportunities for preventionMechanisms linking obesity and cancer
P2860
Q24614006-4C43711B-324D-4E87-8F7F-825854575CDDQ26750563-2D45EA63-01B3-4B79-BC51-8E2B233C4486Q26861403-991DB8C8-31DA-4333-8E4B-4814FCC7D1B1Q26861527-3BF7307B-098E-46FE-96AF-7F720C3854C3Q27004212-BDF82589-529F-44F9-8F17-48DE3B94FBDAQ28115798-691CC26C-89C1-4D54-B271-02789CFA183FQ28116692-5A223D83-4F98-464B-9D9A-AE47EA903299Q28567562-D2FF546A-82BD-4391-93BF-2BBE069E94E6Q30394806-A77B4537-F1C3-4932-96A3-A146C23A5291Q30435726-BFEBFCD6-C67E-4B9F-9063-C91E199C2FDEQ30634120-6014BE66-8587-454E-8C65-8A68C14939FCQ33327933-0EB136F5-0BE5-48BA-9C85-443D405374BCQ33563809-81C280DC-AC68-4AB0-A431-7605709E52C0Q33563815-5AB37642-0C98-4646-9CC3-3EDF9DB0741EQ33665375-08EA1CF5-AEC4-48F3-9667-F067AAD584E3Q33909044-A64C59D4-00CC-4FAD-9CDF-A85C2D0E771FQ33914001-8BE7C11B-BDF9-4284-91E5-B0FA905F4182Q34155989-237B772F-35EA-41F9-B21E-D1B85411F75EQ34541732-4BA03055-5A8D-4BAA-B6A6-ECB5D9EF67BDQ34548342-CD924E07-DFDF-4D04-A777-06470DF7EA46Q34733012-EA9799EA-F06C-4593-A957-81CA476F6F6BQ35018331-DA073A51-49FE-46BC-839B-1B520499EC3CQ35234141-39DF06E7-9AB6-43EE-B445-4266DE557A49Q35547200-9D14F82F-EC6D-40F8-85D9-16C8A1F0C635Q35868202-6BB73C67-B3BD-4FD1-A706-76BA5E352765Q35883606-5130181B-0BBC-44CC-AFBD-60C9216504A8Q35992790-D64ADE28-5572-4B17-8A8D-A866AA5DE465Q36050289-ECBC16B3-EC03-4BE7-94E8-AE6D47B12481Q36140810-AF1ED85E-3A76-4DAD-A4B8-CFFEB69DA3D7Q36142407-518B1162-DF92-44ED-82FC-8A897CC8CF3AQ36410811-67AACFB6-2EC5-467C-A250-AA29DA8897F6Q36462357-2BECFED5-04D7-4802-878C-93897D9E7B1FQ36557474-05E185D2-C03A-4C37-AF65-7BA47CD18A72Q36561207-F6B6BDE7-3322-4342-8DBE-3F3D9DB4AC36Q36567561-9059B5AB-56D7-403B-B594-2342C5AD601EQ36602170-E69DA2CA-F280-41C7-A2E8-BA6227070FFAQ36670639-33553C35-62E5-4B47-B7F7-E3A674B6999EQ36778002-CAE3A9DD-499F-4272-8159-6643DC0E5CF2Q36810924-80A8AD0F-4469-4229-919F-00E7C3EFD191Q37154242-3CF350F0-F3FF-40F4-9F4B-780D4688E2D3
P2860
leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3
description
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2007
@ast
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/05/04)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/05/04)
@nl
наукова стаття, опублікована в травні 2007
@uk
name
leptin-induced growth stimulat ...... omoter via activation of Stat3
@ast
leptin-induced growth stimulat ...... omoter via activation of Stat3
@en
leptin-induced growth stimulat ...... omoter via activation of Stat3
@nl
type
label
leptin-induced growth stimulat ...... omoter via activation of Stat3
@ast
leptin-induced growth stimulat ...... omoter via activation of Stat3
@en
leptin-induced growth stimulat ...... omoter via activation of Stat3
@nl
prefLabel
leptin-induced growth stimulat ...... omoter via activation of Stat3
@ast
leptin-induced growth stimulat ...... omoter via activation of Stat3
@en
leptin-induced growth stimulat ...... omoter via activation of Stat3
@nl
P2093
P2860
P921
P3181
P356
P1476
leptin-induced growth stimulat ...... omoter via activation of Stat3
@en
P2093
Dipali Sharma
Frank A. Anania
Neeraj K. Saxena
Paula M. Vertino
P2860
P304
13316–13325
P3181
P356
10.1074/JBC.M609798200
P407
P577
2007-05-04T00:00:00Z